FLGT
Fulgent Genetics Inc
20.60$
-8.3%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.1% | 21.2% | 11.3% | 6.0% | -21.6% | 32.8% | -6.0% | -36.9% | 13.2% | -93.8% | 10.0% | -27.8% | -25.8% | |
| 7.6% | 9.3% | 10.3% | 8.7% | 8.3% | 8.1% | 8.1% | 7.4% | 7.2% | 7.3% | 8.4% | 7.1% | 7.5% | |
| 12.9% | 16.2% | 17.9% | 16.4% | 15.2% | 13.7% | 14.4% | 12.3% | 11.6% | 11.1% | 13.9% | 21.7% | 14.6% | |
| -13.2% | 14.5% | 7.6% | -3.6% | -35.9% | 21.2% | -13.3% | -47.1% | 2.8% | -86.0% | 23.6% | -18.3% | -21.1% | |
| 5.8% | 4.4% | 6.3% | 18.2% | 27.2% | 5.0% | 6.4% | 8.3% | 7.2% | 6.0% | 7.3% | 4.5% | 6.2% | |
| 23.7% | 34.4% | -73.2% | 10.3% | 12.5% | -36.0% | 37.7% | 65.3% | 22.7% | 13.4% | 15.4% | 59.5% | 28.4% | |
| -3.2% | -34.0% | -3.0% | -0.8% | -0.6% | -0.3% | -14.4% | -3.1% | -0.4% | -0.5% | -56.3% | -27.9% | -20.0% | |
| – | – | – | – | -0.2% | -0.2% | -0.8% | -0.1% | -0.1% | -0.1% | -0.8% | -0.1% | -0.3% | |
| -5.3% | -36.8% | -4.4% | -1.6% | -0.8% | -0.4% | -15.2% | -3.2% | -0.5% | -0.6% | -63.0% | -28.4% | -21.6% | |
| 30.4% | 19.0% | -66.4% | 14.7% | -9.7% | -3.8% | 16.5% | 25.2% | 35.4% | -80.9% | -37.7% | 3.4% | -19.0% | |
| 6.3% | 16.8% | 5.0% | -12.2% | -48.8% | 27.9% | -12.5% | -45.2% | 6.0% | -99.7% | 2.7% | -32.3% | -32.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.